These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15745203)

  • 41. Use and misuse of opioid replacement therapies: a Queensland study.
    Smirnov A; Kemp R
    Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Behavioral health issue brief: pharmacotherapy treatment of alcoholism and drug addiction: overview and bibliography: year end report-2002.
    Colker AC
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-6. PubMed ID: 12875273
    [No Abstract]   [Full Text] [Related]  

  • 43. Should cocaine-abusing, buprenorphine-maintained patients receive auricular acupuncture? Findings from an acute effects study.
    Margolin A; Avants SK
    J Altern Complement Med; 1999 Dec; 5(6):567-74. PubMed ID: 10630350
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities.
    Johnson B; Richert T
    Harm Reduct J; 2019 May; 16(1):31. PubMed ID: 31046774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction.
    Neumann AM; Blondell RD; Jaanimägi U; Giambrone AK; Homish GG; Lozano JR; Kowalik U; Azadfard M
    J Addict Dis; 2013; 32(1):68-78. PubMed ID: 23480249
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Buprenorphine or methadone for detoxification of young opioid addicts?].
    Ebner R; Schreiber W; Zierer C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Substitution therapy in drug addictions].
    Auriacombe M; Fatseas M; Franques-Rénéric P; Daulouède JP; Tignol J
    Rev Prat; 2003 Jun; 53(12):1327-34. PubMed ID: 12920942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    Psychopharmacology (Berl); 1994 Dec; 116(4):401-6. PubMed ID: 7701040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients.
    Peles E; Kreek MJ; Kellogg S; Adelson M
    J Addict Dis; 2006; 25(1):43-50. PubMed ID: 16597572
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies.
    Degenhardt L; Clark B; Macpherson G; Leppan O; Nielsen S; Zahra E; Larance B; Kimber J; Martino-Burke D; Hickman M; Farrell M
    Lancet Psychiatry; 2023 Jun; 10(6):386-402. PubMed ID: 37167985
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Maintenance treatments for opiate -dependent adolescents.
    Minozzi S; Amato L; Bellisario C; Davoli M
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD007210. PubMed ID: 24957634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Community pharmacies and the provision of opioid substitution services for drug misusers: changes in activity and attitudes of community pharmacists across England 1995-2005.
    Sheridan J; Manning V; Ridge G; Mayet S; Strang J
    Addiction; 2007 Nov; 102(11):1824-30. PubMed ID: 17935587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy.
    Harrison TK; Kornfeld H; Aggarwal AK; Lembke A
    Anesthesiol Clin; 2018 Sep; 36(3):345-359. PubMed ID: 30092933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
    J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.
    Wakeman SE; Larochelle MR; Ameli O; Chaisson CE; McPheeters JT; Crown WH; Azocar F; Sanghavi DM
    JAMA Netw Open; 2020 Feb; 3(2):e1920622. PubMed ID: 32022884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
    Yarborough BJ; Stumbo SP; McCarty D; Mertens J; Weisner C; Green CA
    Drug Alcohol Depend; 2016 Mar; 160():112-8. PubMed ID: 26796596
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients.
    Herscher M; Fine M; Navalurkar R; Hirt L; Wang L
    Med Clin North Am; 2020 Jul; 104(4):695-708. PubMed ID: 32505261
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks.
    Camenga DR; Colon-Rivera HA; Muvvala SB
    J Stud Alcohol Drugs; 2019 Jul; 80(4):393-402. PubMed ID: 31495374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opioid dependence treatment: options in pharmacotherapy.
    Stotts AL; Dodrill CL; Kosten TR
    Expert Opin Pharmacother; 2009 Aug; 10(11):1727-40. PubMed ID: 19538000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.